Viewing Study NCT00790894


Ignite Creation Date: 2025-12-25 @ 1:41 AM
Ignite Modification Date: 2026-03-05 @ 2:25 PM
Study NCT ID: NCT00790894
Status: TERMINATED
Last Update Posted: 2011-05-18
First Post: 2008-11-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Trial of Ixabepilone in Patients With HER-2 Negative Metastatic Breast Cancer (HIT)
Sponsor: Hellenic Cooperative Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module